Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Carrier screening for spinal muscular atrophy with a simple test based on melting analysis


Carrier screening of spinal muscular atrophy (SMA) can provide reproductive options for carriers and prevent the birth defects. Here, we developed a simple screening test based on melting analysis. The test comprises a duplex PCR with two primer pairs and three probes to simultaneous amplify SMN1, SMN2, and CFTR. By analyzing the melting profiles, we were able to determine the SMN1/SMN2 ratio and SMN1 + SMN2 copy number to subsequently determine the copy number of SMN1. Samples with one copy of SMN1 were considered as “high risk for carrier,” while samples with ≥2 copies of SMN1 were considered as “low risk for carrier.” We evaluated the clinical performance of this test using 215 clinical samples with various genotypes that had been previously confirmed by multiplex ligation-dependent probe amplification (MLPA). The test showed high sensitivity (100%) and specificity (97.1%) as well as high positive (97.3%) and negative (100%) predictive value, and was in perfect agreement with the gold standard test, MLPA (k = 0.97). Moreover, it is rapid, inexpensive, and easy to perform and automate, with high reproducibility and capacity. Therefore, we expect this test will advance carrier screening for SMA.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5


  1. 1.

    Minino AM, Xu J, Kochanek KD. Deaths: preliminary data for 2008. Natl Vital Stat Rep. 2010;59:1–52.

    PubMed  Google Scholar 

  2. 2.

    Sugarman EA, Nagan N, Zhu H, Akmaev VR, Zhou Z, Rohlfs EM, et al. Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72,400 specimens. Eur J Hum Genet. 2012;20:27–32.

    Article  Google Scholar 

  3. 3.

    Munsat TL, Davies KE. International SMA consortium meeting. (26–28 June 1992, Bonn, Germany). Neuromuscul Disord. 1992;2:423–8.

    CAS  Article  Google Scholar 

  4. 4.

    Er TK, Kan TM, Su YF, Liu TC, Chang JG, Hung SY, et al. High-resolution melting (HRM) analysis as a feasible method for detecting spinal muscular atrophy via dried blood spots. Clin Chim Acta. 2012;413:1781–5.

    CAS  Article  Google Scholar 

  5. 5.

    Lefebvre S, Burglen L, Reboullet S, Clermont O, Burlet P, Viollet L, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell . 1995;80:155–65.

    CAS  Article  Google Scholar 

  6. 6.

    Wirth B. An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA). Hum Mutat. 2000;15:228–37.

    CAS  Article  Google Scholar 

  7. 7.

    Kashima T, Manley JL. A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy. Nat Genet. 2003;34:460–3.

    CAS  Article  Google Scholar 

  8. 8.

    Gavrilov DK, Shi X, Das K, Gilliam TC, Wang CH. Differential SMN2 expression associated with SMA severity. Nat Genet. 1998;20:230–1.

    CAS  Article  Google Scholar 

  9. 9.

    Prior TW. Carrier screening for spinal muscular atrophy. Genet Med. 2008;10:840–2.

    Article  Google Scholar 

  10. 10.

    ACOG Committee on Genetics. ACOG committee opinion No. 432: spinal muscular atrophy. Obstet Gynecol. 2009;113:1194–6.

  11. 11.

    Muralidharan K, Wilson RB, Ogino S, Nagan N, Curtis C, Schrijver I. Population carrier screening for spinal muscular atrophy a position statement of the association for molecular pathology. J Mol Diagn. 2011;13:3–6.

    Article  Google Scholar 

  12. 12.

    Prior TW, Nagan N, Sugarman EA, Batish SD, Braastad C. Technical standards and guidelines for spinal muscular atrophy testing. Genet Med. 2011;13:686–94.

    Article  Google Scholar 

  13. 13.

    Zhou Y, Ge Y, Xiao L, Guo Q. Rapid and simultaneous screening of 47,XXY and AZF microdeletions by quadruplex real-time polymerase chain reaction. Reprod Biol. 2015;15:113–21.

    Article  Google Scholar 

  14. 14.

    Scarciolla O, Stuppia L, De Angelis MV, Murru S, Palka C, Giuliani R, et al. Spinal muscular atrophy genotyping by gene dosage using multiple ligation-dependent probe amplification. Neurogenetics . 2006;7:269–76.

    CAS  Article  Google Scholar 

  15. 15.

    Kruskal WH, Wallis WA. Use of ranks in one-criterion variance analysis. J Am Stat Assoc. 1952;47:583–621.

    Article  Google Scholar 

  16. 16.

    Arkblad EL, Darin N, Berg K, Kimber E, Brandberg G, Lindberg C, et al. Multiplex ligation-dependent probe amplification improves diagnostics in spinal muscular atrophy. Neuromuscul Disord. 2006;16:830–8.

    Article  Google Scholar 

  17. 17.

    Zhong Q, Bhattacharya S, Kotsopoulos S, Olson J, Taly V, Griffiths AD, et al. Multiplex digital PCR: breaking the one target per color barrier of quantitative PCR. Lab Chip. 2011;11:2167–74.

    CAS  Article  Google Scholar 

  18. 18.

    Stabley DL, Holbrook J, Harris AW, Swoboda KJ, Crawford TO, Sol-Church K, et al. Establishing a reference dataset for the authentication of spinal muscular atrophy cell lines using STR profiling and digital PCR. Neuromuscul Disord. 2017;27:439–46.

    Article  Google Scholar 

  19. 19.

    Larson JL, Silver AJ, Chan D, Borroto C, Spurrier B, Silver LM. Validation of a high resolution NGS method for detecting spinal muscular atrophy carriers among phase 3 participants in the 1000 Genomes Project. BMC Med Genet. 2015;16:100.

    Article  Google Scholar 

  20. 20.

    Stabley DL, Harris AW, Holbrook J, Chubbs NJ, Lozo KW, Crawford TO, et al. SMN1 and SMN2 copy numbers in cell lines derived from patients with spinal muscular atrophy as measured by array digital PCR. Mol Genet Genom Med. 2015;3:248–57.

    CAS  Article  Google Scholar 

  21. 21.

    Chien YH, Chiang SC, Weng WC, Lee NC, Lin CJ, Hsieh WS, et al. Presymptomatic diagnosis of spinal muscular atrophy through newborn screening. J Pediatr. 2017;190:124–9 e121.

    Article  Google Scholar 

  22. 22.

    Prior TW, Snyder PJ, Rink BD, Pearl DK, Pyatt RE, Mihal DC, et al. Newborn and carrier screening for spinal muscular atrophy. Am J Med Genet A. 2010;152A:1608–16.

    CAS  Article  Google Scholar 

  23. 23.

    Pyatt RE, Mihal DC, Prior TW. Assessment of liquid microbead arrays for the screening of newborns for spinal muscular atrophy. Clin Chem. 2007;53:1879–85.

    CAS  Article  Google Scholar 

  24. 24.

    Maranda B, Fan L, Soucy JF, Simard L, Mitchell GA. Spinal muscular atrophy: clinical validation of a single-tube multiplex real time PCR assay for determination of SMN1 and SMN2 copy numbers. Clin Biochem. 2012;45:88–91.

    CAS  Article  Google Scholar 

  25. 25.

    Gomez-Curet I, Robinson KG, Funanage VL, Crawford TO, Scavina M, Wang W. Robust quantification of the SMN gene copy number by real-time TaqMan PCR. Neurogenetics. 2007;8:271–8.

    CAS  Article  Google Scholar 

  26. 26.

    Zhang X, Wang B, Zhang L, You G, Palais RA, Zhou L, et al. Accurate diagnosis of spinal muscular atrophy and 22q11.2 deletion syndrome using limited deoxynucleotide triphosphates and high-resolution melting. BMC Genom. 2018;19:485.

    CAS  Article  Google Scholar 

  27. 27.

    Zhou L, Palais RA, Paxton CN, Geiersbach KB, Wittwer CT. Copy number assessment by competitive PCR with limiting deoxynucleotide triphosphates and high-resolution melting. Clin Chem. 2015;61:724–33.

    CAS  Article  Google Scholar 

  28. 28.

    Wang KC, Chang CC, Chang YF, Wang SH, Chiang CK, Tsai CP. Evaluation and characterization of a high-resolution melting analysis kit for rapid carrier-screening test of spinal muscular atrophy. J Neurogenet. 2015;29:113–6.

    Article  Google Scholar 

  29. 29.

    Cusco I, Barcelo MJ, del Rio E, Martin Y, Hernandez-Chico C, Bussaglia E, et al. Characterisation of SMN hybrid genes in Spanish SMA patients: de novo, homozygous and compound heterozygous cases. Hum Genet. 2001;108:222–9.

    CAS  Article  Google Scholar 

  30. 30.

    MacDonald WK, Hamilton D, Kuhle S. SMA carrier testing: a meta-analysis of differences in test performance by ethnic group. Prenat Diagn. 2014;34:1219–26.

    Article  Google Scholar 

Download references


We would like to thank the patients and their families for their contributions in this study. This work was supported by the Foundation for Young Scholars of Fujian Provincial Department of Health Office (project no. 2017-2-107), National Natural Science Foundation of China (project No. 81572084), and Xiamen Science and Technology Major Project (project No. 3502Z20171006).



This work was supported by the Foundation for Young Scholars of Fujian Provincial Department of Health Office (project no. 2017-2-107), National Natural Science Foundation of China (project No. 81572084), and Xiamen Science and Technology Major Project (project No. 3502Z20171006).

Author information



Corresponding authors

Correspondence to Jun Ren or Qiwei Guo.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Xia, Z., Zhou, Y., Fu, D. et al. Carrier screening for spinal muscular atrophy with a simple test based on melting analysis. J Hum Genet 64, 387–396 (2019).

Download citation

Further reading


Quick links